ESPOSITO, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 247.120
NA - Nord America 12.021
AS - Asia 4.784
SA - Sud America 741
Continente sconosciuto - Info sul continente non disponibili 585
AF - Africa 202
OC - Oceania 7
Totale 265.460
Nazione #
IT - Italia 244.389
US - Stati Uniti d'America 11.784
SG - Singapore 1.802
CN - Cina 1.658
SE - Svezia 641
UA - Ucraina 604
BR - Brasile 549
VN - Vietnam 401
DE - Germania 341
FI - Finlandia 301
FR - Francia 237
GB - Regno Unito 217
HK - Hong Kong 144
IN - India 143
CA - Canada 139
RU - Federazione Russa 96
KR - Corea 92
BD - Bangladesh 84
AR - Argentina 81
NL - Olanda 65
MA - Marocco 58
TR - Turchia 58
IL - Israele 56
JP - Giappone 54
IQ - Iraq 50
ZA - Sudafrica 42
PK - Pakistan 41
PL - Polonia 40
AT - Austria 39
MX - Messico 37
EC - Ecuador 35
ES - Italia 35
SC - Seychelles 34
ID - Indonesia 27
SA - Arabia Saudita 23
UZ - Uzbekistan 22
BE - Belgio 21
VE - Venezuela 21
CO - Colombia 19
TN - Tunisia 17
IE - Irlanda 15
IR - Iran 15
KE - Kenya 13
PH - Filippine 13
EG - Egitto 11
TW - Taiwan 11
AZ - Azerbaigian 10
CR - Costa Rica 10
AE - Emirati Arabi Uniti 9
CZ - Repubblica Ceca 9
DZ - Algeria 9
JO - Giordania 9
NI - Nicaragua 9
CL - Cile 8
EU - Europa 8
GE - Georgia 8
NP - Nepal 8
BO - Bolivia 7
JM - Giamaica 7
LT - Lituania 7
PR - Porto Rico 7
PT - Portogallo 7
UY - Uruguay 7
AM - Armenia 6
CW - ???statistics.table.value.countryCode.CW??? 6
KZ - Kazakistan 6
LV - Lettonia 6
MY - Malesia 6
NO - Norvegia 6
PE - Perù 6
AL - Albania 5
AU - Australia 5
CH - Svizzera 5
GR - Grecia 5
HN - Honduras 5
KG - Kirghizistan 5
LB - Libano 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
DK - Danimarca 4
ET - Etiopia 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
RO - Romania 4
SV - El Salvador 4
TH - Thailandia 4
DO - Repubblica Dominicana 3
GP - Guadalupe 3
LU - Lussemburgo 3
MU - Mauritius 3
A1 - Anonimo 2
BB - Barbados 2
CI - Costa d'Avorio 2
EE - Estonia 2
KH - Cambogia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
Totale 264.863
Città #
Cagliari 238.343
Uta 5.175
Ashburn 1.454
Singapore 956
Fairfield 825
San Jose 769
Woodbridge 764
Dallas 559
Chandler 541
Boardman 448
Houston 428
Nyköping 418
Seattle 371
Wilmington 363
Ann Arbor 352
Beijing 339
New York 308
Cambridge 306
Jacksonville 290
Council Bluffs 267
Los Angeles 219
Dearborn 198
Santa Clara 196
Helsinki 184
Shanghai 131
The Dalles 128
Hong Kong 127
Lauterbourg 124
Nanjing 119
Boston 110
Ho Chi Minh City 109
Hefei 104
Rome 93
Seoul 81
Hanoi 76
Dong Ket 69
Buffalo 67
Redwood City 64
Munich 55
Milan 54
Columbus 53
San Diego 50
Chicago 49
Tokyo 43
Atlanta 41
Phoenix 41
Redondo Beach 41
São Paulo 41
Guangzhou 40
Herndon 40
Casablanca 39
Toronto 37
Nanchang 36
Amsterdam 32
Changsha 32
Warsaw 32
London 31
Mountain View 31
Shenyang 31
Tianjin 31
Montreal 28
Orem 28
Rio de Janeiro 25
Vienna 25
Brooklyn 24
Frankfurt am Main 24
Hebei 24
Naples 22
North Bergen 22
Washington 22
Baghdad 21
Denver 21
Jiaxing 21
Chennai 20
Orange 20
Princeton 20
Istanbul 19
Tashkent 19
Guayaquil 18
Hangzhou 18
Johannesburg 18
Norwalk 18
Ottawa 18
San Francisco 18
Mumbai 17
Shenzhen 17
Da Nang 16
Sassari 16
Turku 16
Jinan 15
Lappeenranta 15
Nuremberg 15
Pune 15
Verona 15
Wuhan 15
Stockholm 14
Brussels 13
Kunming 13
Lahore 13
Zhengzhou 13
Totale 257.106
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.761
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.563
Biological activities of aerial parts extracts of Euphorbia characias 4.462
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.362
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.779
Euphorbia characias latex: Micromorphology of rubber particles and rubber transferase activity 3.692
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.537
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.524
Dual HIV-1 reverse transcriptase and integrase inhibitors from Limonium morisianum Arrigoni, an endemic species of Sardinia (Italy) 3.470
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.464
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.388
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.340
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.328
New insights into the operative network of FaEO, an enone oxidoreductase from Fragaria x ananassa Duch 3.130
S-layer proteins as a source of carotenoids: Isolation of the carotenoid cofactor deinoxanthin from its S-layer protein DR_2577 3.112
Inhibition of HIV-1 reverse transcriptase dimerization by small molecules 3.104
Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication 3.070
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.067
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 3.021
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 3.019
Purification and characterization of DR_2577 (SlpA) a major S-layer protein from Deinococcus radiodurans 2.992
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.974
Preliminary study of endemic plants of Sardinia as a source of new antiviral agents 2.965
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 2.953
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.947
Structure-guided approach identifies a novel class of HIV-1 Ribonuclease H inhibitors: Binding mode insights through magnesium complexation and site-directed mutagenesis studies 2.908
Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities 2.896
Chelation motifs affecting metal-dependent viral enzymes: N′-acylhydrazone ligands as dual target inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H domain 2.894
On the S-layer of Thermus thermophilus and the assembling of its main protein SIpA 2.874
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding 2.840
RhVI1 is a membrane-anchored vacuolar invertase highly expressed in Rosa hybrida L. petals 2.837
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.801
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.751
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H 2.727
null 2.719
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.645
Identification of a novel HERV-K(HML10): comprehensive characterization and comparative analysis in non-human primates provide insights about HML10 proviruses structure and diffusion 2.595
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.490
Structure-Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain 2.452
Inhibition of HIV-1 reverse transcriptase associated activities by the hydroalcoholic extract of Casimiroa edulis seeds 2.436
Validation of a computed radiography device to monitor the HIV-1 RNase H activity 2.422
An efficient route to novel uracil-based drug-like molecules 2.388
Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities 2.387
Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops 2.368
A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35–Associated Inhibition of Double-Stranded RNA–Stimulated, Retinoic Acid–Inducible Gene 1–Mediated Induction of Interferon β 2.338
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.296
2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication 2.287
Development and identification of a novel anti-HIV-1 peptide derived by modification of the N-terminal domain of HIV-1 integrase 2.234
Investigation on the sucrose binding pocket of HIV-1 Integrase by molecular dynamics and synergy experiments 2.231
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.191
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.173
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors 2.156
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants 2.134
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases 2.131
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.115
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 2.109
Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: molecular modeling and biological evaluation 2.088
6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach 2.061
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.019
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 1.924
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.905
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase 1.902
Scaffold hopping and optimisation of 3’,4’-dihydroxyphenyl- containing thienopyrimidinones: synthesis of quinazolinone derivatives as novel allosteric inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H 1.852
null 1.851
The traditional Chinese medicine plant Schisandra Chinensis as source of new HIV-1 reverse transcriptase inhibitor scaffolds effective also on non-nucleoside resistant reverse transcriptases 1.843
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.837
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.826
null 1.820
Inhibition of HIV-1 Ribonuclease H activity by novel frangula-emodine derivatives 1.775
HIV-1 inhibiting activity of the essential oil of Ridolfia segetum and Oenanthe crocata 1.770
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.748
New anthraquinone derivatives as inhibitors of the HIV-1 reverse transcriptase-associated ribonuclease H function 1.737
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and Ribonuclease H activities effective also on non-nucleoside resistant RTs 1.734
dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35 1.723
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.637
Effects of new quinizarin derivatives on both HCV NS5B RNA polymerase and HIV-1 reverse transcriptase associated ribonuclease H activities 1.620
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen 1.604
From classic to innovative approaches in HIV-1 infection treatment 1.598
Development of a Raltegravir-based Photoaffinity-Labeled Probe for Human Immunodeficiency Virus-1 Integrase Capture 1.581
Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives 1.562
Anti-HIV-1 activity of compounds isolated from Hypericum hircinum. 1.562
Probing the importance of the g-quadruplex grooves for the activity of the anti-hiv-integrase aptamer t30923 1.495
A Homogeneous Time Resolved Fluorescence (HTRF) method for the evaluation of HIV-1 integrase dimerization, enzyme reactions and interaction with LEDGF/p75 1.488
Can the ever-promising target HIV reverse transcriptase-associated RNase H become a success story for drug development? 1.457
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.452
Effect of Non-nucleoside Reverse Transcriptase Inhibitors on the HIV-1 Reverse Transcriptase Associated Ribonuclease-H Activity 1.421
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase (RT) -associated DNA polymerase and Ribonuclease H (RNase H) activities effective also on the RNase H activity of non-nucleoside resistant RTs 1.401
Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities 1.334
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort 1.251
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.229
null 1.214
A combined shape-, 2D-fingerprint-and pharmacophore-based virtual screening for the identification of dual inhibitors targeting HIV-1 reverse transcriptase. 1.209
A combined cell based and site directed mutagenesis approach defines highly conserved residues involved in the selective inhibition of the HIV-1 ribonuclease H function by diketoacid derivatives 1.179
HIV-1 reverse transcriptase and K562 cell replication inhibition by Ridolfia segetum (L.) Moris essential oil 1.174
In Vitro Anti-HIV-1 Reverse Transcriptase and Integrase Properties of Punica granatum L. Leaves, Bark, and Peel Extracts and Their Main Compounds 1.153
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting the main protease Mpro 1.112
Purification and functional characterization of the full length recombinant Ebola virus VP35 protein expressed in E. coli 1.086
Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors 1.066
Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase 1.015
Chemical Characterization and Anti-HIV-1 Activity Assessment of Iridoids and Flavonols from Scrophularia trifoliata 1.005
Totale 241.169
Categoria #
all - tutte 326.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 326.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229.644 0 0 0 0 1.064 1.094 720 579 1.260 1.273 1.812 1.842
2022/202321.107 1.698 2.901 2.540 2.044 1.399 2.491 1.086 1.683 1.162 1.243 1.870 990
2023/202420.613 905 749 1.251 1.736 2.153 3.614 2.934 1.418 986 1.195 1.758 1.914
2024/202544.636 10.914 13.148 6.932 4.236 1.988 2.388 3.362 145 411 305 323 484
2025/202610.856 704 353 1.285 918 938 730 1.638 983 736 1.356 750 465
2026/20273.222 266 536 961 1.300 159 0 0 0 0 0 0 0
Totale 265.460